Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier.
Wan Z, Huang H, West RE 3rd, Zhang M, Zhang B, Cai X, Zhang Z, Luo Z, Chen Y, Zhang Y, Xie W, Yang D, Nolin TD, Wang J, Li S, Sun J.
Wan Z, et al. Among authors: nolin td.
Mater Today (Kidlington). 2023 Jan-Feb;62:33-50. doi: 10.1016/j.mattod.2022.11.008. Epub 2022 Dec 8.
Mater Today (Kidlington). 2023.
PMID: 38239407
Free PMC article.